Press Release FDA grants Breakthrough Therapy Designation for GENENTECH’s investigational medicine ocrelizumab in primary progressive [...]
Many patients with multiple sclerosis (MS) lose the ability to distinguish different tastes -- a signal associated with MS-related lesions [...]
Brigham and Women’s Hospital researchers reported that antibodies directed at lipids are associated with magnetic resonance imaging [...]
Stable multiple sclerosis (MS) patients do not appear to be at any increased risk of disease reactivation while switching to oral therapy [...]
Some people with multiple sclerosis decide to avoid yoga because they believe they won’t be able to do the poses or may feel [...]
A new way of using MRI scanners to look for evidence of multiple sclerosis in the brain has been successfully tested by researchers at The [...]
For patients with multiple sclerosis (MS) who are treated with injectable disease-modifying therapies (DMTs) for more than 2 years, the [...]
A study out today sheds new light on multiple sclerosis (MS), specifically damage in the brain caused by the disease that may explain the [...]
No differences in relapse or progression rates between switchers & stayers over 6 months Multiple sclerosis patients who are well [...]
An anti-convulsant drug used to treat epilepsy may also prevent nerve damage in patients with multiple sclerosis (MS), research has [...]
